tradmap

CELC Celcuity Inc.

$87.68 -0.45%

Healthcare · Services-Medical Laboratories

Celcuity Inc. (CELC) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $4.3 billion. Shares last traded at $87.68, 42.0% below their 52-week high. Over the past year the stock is up 644.3%.

Market Cap
$4.3B
Shares Out
48.8M
EPS (TTM)
$-6.54
P/E Ratio
P/S Ratio
P/B Ratio
79.88
Dividend / Share
Dividend Yield
52-Week High
$151.06
52-Week Low
$11.36
Volume
75,006
Avg Vol (3m)
65,953.714

Performance

1W
-2.18%
1M
-33.07%
3M
-22.35%
6M
-12.65%
YTD
-12.71%
1Y
+644.31%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
32.29
SMA (50)
$118.33
SMA (200)
$97.45
Price vs SMA50
-25.90%
Price vs SMA200
-10.03%
ATR (14)
$7.27

Financials

Revenue
Net Income
$-177M
Gross Margin
Operating Margin
Net Margin
Return on Equity
-330.8%
Return on Assets
-43.2%
Current Ratio
12.31
Debt / Equity
2.58
Revenue Growth (YoY)

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.97 2026-05-14
FY 2025 $-3.79 2026-03-26
Q3 2025 $-2.81 2025-11-13
Q2 2025 $-1.90 2025-08-14
Q1 2026 $-0.86 2026-05-14
FY 2025 $-2.83 2026-03-26

Full earnings history →

Services-Medical Laboratories peers

CELC vs 14 industry peers (Services-Medical Laboratories), by market cap.

1–14 of 14
NTRANatera, Inc.$33.1B-159.2314.37-9.0%+2.17%
DGXQuest Diagnostics$21.6B21.761.969.0%-1.44%
LHLabcorp$21.0B23.931.506.3%-1.40%
GHGuardant Health, Inc.$17.5B-41.9817.80-42.4%+2.06%
CAICaris Life Sciences, Inc.$5.2B+3.41%
BLLNBilliontoone, Inc.$4.8B+5.38%
VCYTVeracyte, Inc.$4.3B64.478.2812.8%+4.50%
CELCCelcuity Inc.$4.3B-24.15-0.45%
RDNTRadnet, Inc.$4.2B-226.562.07-0.9%+1.83%
GRALGrail, Inc.$2.7B+7.35%
FTREFortrea Holdings Inc.$1.4B-0.20%
CDNACaredx, Inc.$1.4B-63.383.56-5.6%+11.89%
PSNLPersonalis, Inc.$1.1B-13.55+8.29%
LMRILumexa Imaging Holdings, Inc.$907M+7.76%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.